Avidity Biosciences Inc - Bathi sadurunge bunga, pajak, lan amortisasi RNA
Avidity Biosciences (RNA) pilot RNA-based drug production capacities are operating in preparation for testing, which correlates with the trend in EBITDA. The value of 0.00 serves as the current indicator of this curve. Future revenue is based on therapy for rare myopathies, however, the business is constrained by a lack of sales, strict FDA oversight, and rapid capital burn during early-stage research.
Ringkesan rincian data analitis Avidity Biosciences, Inc. (RNA)
- rega saiki lan proyeksi nilai saham:
- rincian nilai pasar emiten:
- data kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Koefisien Total Utang marang Modal Avidity Biosciences|RNA - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Avidity Biosciences Inc|RNA - Utang perusahaan|Utang-utang marang aset resik Avidity Biosciences|RNA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Avidity Biosciences|Koefisien jangkoan perantara aviditybiosciences.com
- statistik bathi lan rasio pasar:
RNA - Bathi resik|Bathi resik sing dikarepake Avidity Biosciences|RNA - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep aviditybiosciences.com|RNA - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Avidity Biosciences|RNA - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Avidity Biosciences|RNA - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan aviditybiosciences.com|RNA - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Avidity Biosciences
Analisis kabeh metrik perusahaan:RNA Avidity Corp
This indicator captures real cash flow from core operations, excluding non-cash depreciation and GAAP accounting adjustments to assess true liquidity. Analyzing the EBITDA of Avidity Biosciences (RNA) allows for monitoring the capital burn rate, which is critical for Avidity Biosciences (RNA), as its RNA-based drugs are currently in the development stage and do not yet generate commercial revenue.
Karo sapa Avidity Biosciences saingan
Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TEM (Tempus)|QGEN: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi ionispharma.com|RGEN (Repligen) - Bathi operasional sadurunge ngurangi amortisasi|CRISPR Therapeutics Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|WGS (Sema4) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi RARE|Bathi operasional EBITDA BEAM|Pendapatan operasional sadurunge ngurangi amortisasi sarepta.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Twist Bioscience, Inc. TWST|10x Genomics Inc (TXG) - Bathi sadurunge bunga, pajak, lan amortisasi|NTLA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Stoke Corp STOK|BLFS: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi wavelifesciences.com|MAZE (Maze Therapeutics) - Bathi operasional EBITDA|Sionna Therapeutics, Inc. (SION) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA PRME|TSHA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi uniQure N.V. QURE|MGTX: Bathi operasional sadurunge amortisasi|REGENXBIO - Bathi operasional EBITDA|Solid Biosciences Inc (SLDB) - Bathi operasional sadurunge ngurangi amortisasi|OCGN: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PacBio Corp (PACB)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Benitec Biopharma Inc.|designtx.com (DSGN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Rocket Pharmaceuticals, Inc. (RCKT)|FDMT (4DMT) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lexeo Therapeutics, Inc. LXEO|KRRO: Bathi operasional sadurunge amortisasi|Editas Medicine, Inc. - Bathi operasional EBITDA|SLN - Bathi operasional EBITDA|PRQR: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi CDXS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sangamo|Bathi operasional sadurunge amortisasi NAUT (Nautilus Biotechnology Inc)|Bathi operasional EBITDA MGX|Bathi operasional EBITDA precisionbiosciences.com (DTIL)|Bathi operasional EBITDA GBIO (Generation Bio)|Bathi operasional EBITDA Boundless Bio Inc. BOLD|XCUR: Bathi operasional sadurunge ngurangi amortisasi|IMNN: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PHIO: Bathi operasional EBITDA|MBIO - Pendapatan operasional sadurunge ngurangi amortisasi|RNAZ (TransCode Therapeutics Inc.) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional EBITDA APDN|Pendapatan operasional sadurunge ngurangi amortisasi bluebird bio, Inc|ImmunoPrecise Antibodies Ltd. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi OMGA (omegatherapeutics.com)|OMIC: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Regulus Therapeutics, Inc.|SYRS (Syros) - Bathi operasional sadurunge ngurangi amortisasi|Telesis Bio, Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|TCON (TRACON Pharmaceuticals) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi UBX
